NCT07863934Completed
Effects of High-Intensity Interval Training and Quinoa Supplementation in Women With Type 2 Diabetes
Effects of High-Intensity Interval Training and Quinoa Supplementation on Some Selected Pyroptosis Proteins and Glycemic Control in Women With Type 2 Diabetes: A Randomized Controlled Trial.
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
This study evaluated the effects of eight weeks of high-intensity interval training (HIIT), daily quinoa consumption, and their combination on inflammatory markers and blood glucose control in women aged 50-65 years with type 2 diabetes. Participants were randomly assigned to four groups: HIIT, quinoa consumption, combined HIIT and quinoa consumption, or control. The quinoa groups consumed 25 g of cooked quinoa daily for eight weeks. Blood markers and body measurements were assessed before and after the intervention.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 2 Oct 2026
- Start date
- 16 Oct 2024
- Primary completion date
- 28 Dec 2024
- Lead sponsor
- University of Central Lancashire
- Diseases
- Type 2 diabetes
- NCT number
- NCT07863934
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 16 Oct 2024 to the primary completion date, 28 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current insulin therapy
Other illness
- Diagnosed cardiovascular disease
- Thyroid disorders
Other
- Diabetic foot ulcers
- Recent hospitalization
- Regular participation in a structured exercise programme
- Exercise intolerance, specifically manifested by: discomfort, severe fatigue, imbalance or dizziness
Who the study is looking for
- Female
- 50-65 years of age
- Diagnosed with type 2 diabetes for at least 5 years
- Fasting blood glucose \>126 mg/dL OR HbA1c ≥6.5%
- Receiving metformin therapy
- Able to participate safely in the exercise intervention
- Able and willing to provide written informed consent
Age in the registry: 50 years to 65 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Allameh Tabataba'i University Coordinator of this site? Confirm its status | Tehran | Iran | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.